APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hemostatis and Tissue Sealing Agents

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Hemostatis and Tissue Sealing Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025194 pages

Choose your research edition.

Industry ResearchHemostatis and Tissue Sealing Agents Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Hemostatis and Tissue Sealing Agents Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Hemostatis and Tissue Sealing Agents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hemostatis and Tissue Sealing Agents Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Hemostatis and Tissue Sealing Agents Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Hemostatis and Tissue Sealing Agents market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Hemostatis and Tissue Sealing Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Hemostatis and Tissue Sealing Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hemostatis and Tissue Sealing Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Hemostatis and Tissue Sealing Agents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Hemostatis and Tissue Sealing Agents include Johnson & Johnson, Medtronic, Pfizer Inc., Smith & Nephew, Integra Life Sciences Corporation, HyperBranch Medical Technology, CryoLife Inc., Cohesion Technologies Inc and Cohera Medical Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Hemostatis and Tissue Sealing Agents market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hemostatis and Tissue Sealing Agents and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hemostatis and Tissue Sealing Agents sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hemostatis and Tissue Sealing Agents market size, projected growth trends, production technologies, key applications, and end-use industries.

Hemostatis and Tissue Sealing Agents Segment by Company

Johnson & Johnson

Medtronic

Pfizer Inc.

Smith & Nephew

Integra Life Sciences Corporation

HyperBranch Medical Technology

CryoLife Inc.

Cohesion Technologies Inc

Cohera Medical Inc.

C R Bard Inc.

Biomet Inc.

B Braun Medical Inc.

Advance Medical Solution (AMS) Group Plc.

Hemostatis and Tissue Sealing Agents Segment by Type

Topical Hemostat

Adhesive & Tissue Sealant

Hemostatis and Tissue Sealing Agents Segment by Application

Home Care Settings

Ambulatory Surgical Centers

Hospitals

Others

Hemostatis and Tissue Sealing Agents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemostatis and Tissue Sealing Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hemostatis and Tissue Sealing Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemostatis and Tissue Sealing Agents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hemostatis and Tissue Sealing Agents market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hemostatis and Tissue Sealing Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Hemostatis and Tissue Sealing Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Hemostatis and Tissue Sealing Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Hemostatis and Tissue Sealing Agents Industry Trends Table 2. Hemostatis and Tissue Sealing Agents Industry Drivers Table 3. Hemostatis and Tissue Sealing Agents Industry Opportunities and Challenges Table 4. Hemostatis and Tissue Sealing Agents Industry Restraints Table 5. Global Hemostatis and Tissue Sealing Agents Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Hemostatis and Tissue Sealing Agents Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Hemostatis and Tissue Sealing Agents Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Hemostatis and Tissue Sealing Agents Sales Market Share by Manufacturers Table 9. Global Hemostatis and Tissue Sealing Agents Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Hemostatis and Tissue Sealing Agents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Hemostatis and Tissue Sealing Agents Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Hemostatis and Tissue Sealing Agents Manufacturers, Product Type & Application Table 13. Global Hemostatis and Tissue Sealing Agents Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Hemostatis and Tissue Sealing Agents by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Topical Hemostat Table 17. Major Manufacturers of Adhesive & Tissue Sealant Table 18. Global Hemostatis and Tissue Sealing Agents Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Hemostatis and Tissue Sealing Agents Sales by Type (2021-2026) & (k units) Table 20. Global Hemostatis and Tissue Sealing Agents Sales by Type (2027-2032) & (k units) Table 21. Global Hemostatis and Tissue Sealing Agents Sales Market Share by Type (2021-2026) Table 22. Global Hemostatis and Tissue Sealing Agents Sales Market Share by Type (2027-2032) Table 23. Global Hemostatis and Tissue Sealing Agents Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Hemostatis and Tissue Sealing Agents Revenue by Type (2021-2026) & (k units) Table 25. Global Hemostatis and Tissue Sealing Agents Revenue by Type (2027-2032) & (k units) Table 26. Global Hemostatis and Tissue Sealing Agents Revenue Market Share by Type (2021-2026) Table 27. Global Hemostatis and Tissue Sealing Agents Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Home Care Settings Table 29. Major Manufacturers of Ambulatory Surgical Centers Table 30. Major Manufacturers of Hospitals Table 31. Major Manufacturers of Others Table 32. Global Hemostatis and Tissue Sealing Agents Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Hemostatis and Tissue Sealing Agents Sales by Application (2021-2026) & (k units) Table 34. Global Hemostatis and Tissue Sealing Agents Sales by Application (2027-2032) & (k units) Table 35. Global Hemostatis and Tissue Sealing Agents Sales Market Share by Application (2021-2026) Table 36. Global Hemostatis and Tissue Sealing Agents Sales Market Share by Application (2027-2032) Table 37. Global Hemostatis and Tissue Sealing Agents Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Hemostatis and Tissue Sealing Agents Revenue by Application (2021-2026) & (k units) Table 39. Global Hemostatis and Tissue Sealing Agents Revenue by Application (2027-2032) & (k units) Table 40. Global Hemostatis and Tissue Sealing Agents Revenue Market Share by Application (2021-2026) Table 41. Global Hemostatis and Tissue Sealing Agents Revenue Market Share by Application (2027-2032) Table 42. Global Hemostatis and Tissue Sealing Agents Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Hemostatis and Tissue Sealing Agents Sales by Region (2021-2026) & (k units) Table 44. Global Hemostatis and Tissue Sealing Agents Sales Market Share by Region (2021-2026) Table 45. Global Hemostatis and Tissue Sealing Agents Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Hemostatis and Tissue Sealing Agents Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Hemostatis and Tissue Sealing Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Hemostatis and Tissue Sealing Agents Sales by Country (2021-2026) & (k units) Table 49. North America Hemostatis and Tissue Sealing Agents Sales by Country (2027-2032) & (k units) Table 50. Europe Hemostatis and Tissue Sealing Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Hemostatis and Tissue Sealing Agents Sales by Country (2021-2026) & (k units) Table 52. Europe Hemostatis and Tissue Sealing Agents Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Hemostatis and Tissue Sealing Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Hemostatis and Tissue Sealing Agents Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Hemostatis and Tissue Sealing Agents Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Hemostatis and Tissue Sealing Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Hemostatis and Tissue Sealing Agents Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Hemostatis and Tissue Sealing Agents Sales by Country (2027-2032) & (k units) Table 59. Global Hemostatis and Tissue Sealing Agents Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Hemostatis and Tissue Sealing Agents Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Hemostatis and Tissue Sealing Agents Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Hemostatis and Tissue Sealing Agents Revenue Market Share by Region (2021-2026) Table 63. Global Hemostatis and Tissue Sealing Agents Revenue Market Share by Region (2027-2032) Table 64. Johnson & Johnson Company Information Table 65. Johnson & Johnson Business Overview Table 66. Johnson & Johnson Hemostatis and Tissue Sealing Agents Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Johnson & Johnson Hemostatis and Tissue Sealing Agents Product Portfolio Table 68. Johnson & Johnson Recent Development Table 69. Medtronic Company Information Table 70. Medtronic Business Overview Table 71. Medtronic Hemostatis and Tissue Sealing Agents Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Medtronic Hemostatis and Tissue Sealing Agents Product Portfolio Table 73. Medtronic Recent Development Table 74. Pfizer Inc. Company Information Table 75. Pfizer Inc. Business Overview Table 76. Pfizer Inc. Hemostatis and Tissue Sealing Agents Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Pfizer Inc. Hemostatis and Tissue Sealing Agents Product Portfolio Table 78. Pfizer Inc. Recent Development Table 79. Smith & Nephew Company Information Table 80. Smith & Nephew Business Overview Table 81. Smith & Nephew Hemostatis and Tissue Sealing Agents Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Smith & Nephew Hemostatis and Tissue Sealing Agents Product Portfolio Table 83. Smith & Nephew Recent Development Table 84. Integra Life Sciences Corporation Company Information Table 85. Integra Life Sciences Corporation Business Overview Table 86. Integra Life Sciences Corporation Hemostatis and Tissue Sealing Agents Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Integra Life Sciences Corporation Hemostatis and Tissue Sealing Agents Product Portfolio Table 88. Integra Life Sciences Corporation Recent Development Table 89. HyperBranch Medical Technology Company Information Table 90. HyperBranch Medical Technology Business Overview Table 91. HyperBranch Medical Technology Hemostatis and Tissue Sealing Agents Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. HyperBranch Medical Technology Hemostatis and Tissue Sealing Agents Product Portfolio Table 93. HyperBranch Medical Technology Recent Development Table 94. CryoLife Inc. Company Information Table 95. CryoLife Inc. Business Overview Table 96. CryoLife Inc. Hemostatis and Tissue Sealing Agents Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. CryoLife Inc. Hemostatis and Tissue Sealing Agents Product Portfolio Table 98. CryoLife Inc. Recent Development Table 99. Cohesion Technologies Inc Company Information Table 100. Cohesion Technologies Inc Business Overview Table 101. Cohesion Technologies Inc Hemostatis and Tissue Sealing Agents Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Cohesion Technologies Inc Hemostatis and Tissue Sealing Agents Product Portfolio Table 103. Cohesion Technologies Inc Recent Development Table 104. Cohera Medical Inc. Company Information Table 105. Cohera Medical Inc. Business Overview Table 106. Cohera Medical Inc. Hemostatis and Tissue Sealing Agents Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Cohera Medical Inc. Hemostatis and Tissue Sealing Agents Product Portfolio Table 108. Cohera Medical Inc. Recent Development Table 109. C R Bard Inc. Company Information Table 110. C R Bard Inc. Business Overview Table 111. C R Bard Inc. Hemostatis and Tissue Sealing Agents Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. C R Bard Inc. Hemostatis and Tissue Sealing Agents Product Portfolio Table 113. C R Bard Inc. Recent Development Table 114. Biomet Inc. Company Information Table 115. Biomet Inc. Business Overview Table 116. Biomet Inc. Hemostatis and Tissue Sealing Agents Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Biomet Inc. Hemostatis and Tissue Sealing Agents Product Portfolio Table 118. Biomet Inc. Recent Development Table 119. B Braun Medical Inc. Company Information Table 120. B Braun Medical Inc. Business Overview Table 121. B Braun Medical Inc. Hemostatis and Tissue Sealing Agents Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. B Braun Medical Inc. Hemostatis and Tissue Sealing Agents Product Portfolio Table 123. B Braun Medical Inc. Recent Development Table 124. Advance Medical Solution (AMS) Group Plc. Company Information Table 125. Advance Medical Solution (AMS) Group Plc. Business Overview Table 126. Advance Medical Solution (AMS) Group Plc. Hemostatis and Tissue Sealing Agents Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Advance Medical Solution (AMS) Group Plc. Hemostatis and Tissue Sealing Agents Product Portfolio Table 128. Advance Medical Solution (AMS) Group Plc. Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Hemostatis and Tissue Sealing Agents Distributors List Table 132. Hemostatis and Tissue Sealing Agents Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Hemostatis and Tissue Sealing Agents Product Image Figure 2. Global Hemostatis and Tissue Sealing Agents Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hemostatis and Tissue Sealing Agents Market Size (2021-2032) & (US$ Million) Figure 4. Global Hemostatis and Tissue Sealing Agents Sales (2021-2032) & (k units) Figure 5. Global Hemostatis and Tissue Sealing Agents Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Hemostatis and Tissue Sealing Agents Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Topical Hemostat Image Figure 9. Adhesive & Tissue Sealant Image Figure 10. Global Hemostatis and Tissue Sealing Agents Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Hemostatis and Tissue Sealing Agents Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Hemostatis and Tissue Sealing Agents Sales Market Share by Type (2021-2032) Figure 13. Global Hemostatis and Tissue Sealing Agents Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Hemostatis and Tissue Sealing Agents Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Hemostatis and Tissue Sealing Agents Revenue Market Share by Type (2021-2032) Figure 16. Home Care Settings Image Figure 17. Ambulatory Surgical Centers Image Figure 18. Hospitals Image Figure 19. Others Image Figure 20. Global Hemostatis and Tissue Sealing Agents Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Hemostatis and Tissue Sealing Agents Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Hemostatis and Tissue Sealing Agents Sales Market Share by Application (2021-2032) Figure 23. Global Hemostatis and Tissue Sealing Agents Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Hemostatis and Tissue Sealing Agents Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Hemostatis and Tissue Sealing Agents Revenue Market Share by Application (2021-2032) Figure 26. North America Hemostatis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Hemostatis and Tissue Sealing Agents Sales Market Share by Country (2021-2032) Figure 28. U.S. Hemostatis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Hemostatis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Hemostatis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Hemostatis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Hemostatis and Tissue Sealing Agents Sales Market Share by Country (2021-2032) Figure 33. Germany Hemostatis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Hemostatis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Hemostatis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Hemostatis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Hemostatis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Hemostatis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Hemostatis and Tissue Sealing Agents Sales Market Share by Country (2021-2032) Figure 40. China Hemostatis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Hemostatis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Hemostatis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Hemostatis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Hemostatis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Hemostatis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Hemostatis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Hemostatis and Tissue Sealing Agents Sales Market Share by Country (2021-2032) Figure 48. Brazil Hemostatis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Hemostatis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Hemostatis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Hemostatis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Hemostatis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Hemostatis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Hemostatis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Hemostatis and Tissue Sealing Agents Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Hemostatis and Tissue Sealing Agents Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Hemostatis and Tissue Sealing Agents Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Hemostatis and Tissue Sealing Agents Revenue (2021-2032) & (US$ Million) Figure 59. North America Hemostatis and Tissue Sealing Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Hemostatis and Tissue Sealing Agents Revenue (2021-2032) & (US$ Million) Figure 61. Europe Hemostatis and Tissue Sealing Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Hemostatis and Tissue Sealing Agents Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Hemostatis and Tissue Sealing Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Hemostatis and Tissue Sealing Agents Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Hemostatis and Tissue Sealing Agents Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Hemostatis and Tissue Sealing Agents Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Hemostatis and Tissue Sealing Agents Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Topical Hemostat
  • Adhesive & Tissue Sealant
Applications
  • Home Care Settings
  • Ambulatory Surgical Centers
  • Hospitals
  • Others
Companies covered
  • Johnson & Johnson
  • Medtronic
  • Pfizer Inc.
  • Smith & Nephew
  • Integra Life Sciences Corporation
  • HyperBranch Medical Technology
  • CryoLife Inc.
  • Cohesion Technologies Inc
  • Cohera Medical Inc.
  • C R Bard Inc.
  • Biomet Inc.
  • B Braun Medical Inc.
  • Advance Medical Solution (AMS) Group Plc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Hemostatis and Tissue Sealing Agents Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Hemostatis and Tissue Sealing Agents Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Hemostatis and Tissue Sealing Agents Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Hemostatis and Tissue Sealing Agents Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Hemostatis and Tissue Sealing Agents Market Dynamics
  1. 2.1 Hemostatis and Tissue Sealing Agents Industry Trends
  2. 2.2 Hemostatis and Tissue Sealing Agents Industry Drivers
  3. 2.3 Hemostatis and Tissue Sealing Agents Industry Opportunities and Challenges
  4. 2.4 Hemostatis and Tissue Sealing Agents Industry Restraints
3 Hemostatis and Tissue Sealing Agents Market by Manufacturers
  1. 3.1 Global Hemostatis and Tissue Sealing Agents Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Hemostatis and Tissue Sealing Agents Sales by Manufacturers (2021-2026)
  3. 3.3 Global Hemostatis and Tissue Sealing Agents Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Hemostatis and Tissue Sealing Agents Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hemostatis and Tissue Sealing Agents Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Hemostatis and Tissue Sealing Agents Manufacturers, Product Type & Application
  7. 3.7 Global Hemostatis and Tissue Sealing Agents Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hemostatis and Tissue Sealing Agents Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hemostatis and Tissue Sealing Agents Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hemostatis and Tissue Sealing Agents Tier 1, Tier 2, and Tier 3
4 Hemostatis and Tissue Sealing Agents Market by Type
  1. 4.1 Hemostatis and Tissue Sealing Agents Type Introduction
  2. 4.1.1 Topical Hemostat
  3. 4.1.2 Adhesive & Tissue Sealant
  4. 4.2 Global Hemostatis and Tissue Sealing Agents Sales by Type
  5. 4.2.1 Global Hemostatis and Tissue Sealing Agents Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Hemostatis and Tissue Sealing Agents Sales by Type (2021-2032)
  7. 4.2.3 Global Hemostatis and Tissue Sealing Agents Sales Market Share by Type (2021-2032)
  8. 4.3 Global Hemostatis and Tissue Sealing Agents Revenue by Type
  9. 4.3.1 Global Hemostatis and Tissue Sealing Agents Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Hemostatis and Tissue Sealing Agents Revenue by Type (2021-2032)
  11. 4.3.3 Global Hemostatis and Tissue Sealing Agents Revenue Market Share by Type (2021-2032)
5 Hemostatis and Tissue Sealing Agents Market by Application
  1. 5.1 Hemostatis and Tissue Sealing Agents Application Introduction
  2. 5.1.1 Home Care Settings
  3. 5.1.2 Ambulatory Surgical Centers
  4. 5.1.3 Hospitals
  5. 5.1.4 Others
  6. 5.2 Global Hemostatis and Tissue Sealing Agents Sales by Application
  7. 5.2.1 Global Hemostatis and Tissue Sealing Agents Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Hemostatis and Tissue Sealing Agents Sales by Application (2021-2032)
  9. 5.2.3 Global Hemostatis and Tissue Sealing Agents Sales Market Share by Application (2021-2032)
  10. 5.3 Global Hemostatis and Tissue Sealing Agents Revenue by Application
  11. 5.3.1 Global Hemostatis and Tissue Sealing Agents Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Hemostatis and Tissue Sealing Agents Revenue by Application (2021-2032)
  13. 5.3.3 Global Hemostatis and Tissue Sealing Agents Revenue Market Share by Application (2021-2032)
6 Global Hemostatis and Tissue Sealing Agents Sales by Region
  1. 6.1 Global Hemostatis and Tissue Sealing Agents Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hemostatis and Tissue Sealing Agents Sales by Region (2021-2032)
  3. 6.2.1 Global Hemostatis and Tissue Sealing Agents Sales by Region (2021-2026)
  4. 6.2.2 Global Hemostatis and Tissue Sealing Agents Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Hemostatis and Tissue Sealing Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Hemostatis and Tissue Sealing Agents Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Hemostatis and Tissue Sealing Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Hemostatis and Tissue Sealing Agents Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Hemostatis and Tissue Sealing Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Hemostatis and Tissue Sealing Agents Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Hemostatis and Tissue Sealing Agents Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Hemostatis and Tissue Sealing Agents Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Hemostatis and Tissue Sealing Agents Revenue by Region
  1. 7.1 Global Hemostatis and Tissue Sealing Agents Revenue by Region
  2. 7.1.1 Global Hemostatis and Tissue Sealing Agents Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Hemostatis and Tissue Sealing Agents Revenue by Region (2021-2026)
  4. 7.1.3 Global Hemostatis and Tissue Sealing Agents Revenue by Region (2027-2032)
  5. 7.1.4 Global Hemostatis and Tissue Sealing Agents Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Hemostatis and Tissue Sealing Agents Revenue (2021-2032)
  8. 7.2.2 North America Hemostatis and Tissue Sealing Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Hemostatis and Tissue Sealing Agents Revenue (2021-2032)
  11. 7.3.2 Europe Hemostatis and Tissue Sealing Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Hemostatis and Tissue Sealing Agents Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Hemostatis and Tissue Sealing Agents Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Hemostatis and Tissue Sealing Agents Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Hemostatis and Tissue Sealing Agents Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson & Johnson
  2. 8.1.1 Johnson & Johnson Company Information
  3. 8.1.2 Johnson & Johnson Business Overview
  4. 8.1.3 Johnson & Johnson Hemostatis and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Johnson & Johnson Hemostatis and Tissue Sealing Agents Product Portfolio
  6. 8.1.5 Johnson & Johnson Recent Developments
  7. 8.2 Medtronic
  8. 8.2.1 Medtronic Company Information
  9. 8.2.2 Medtronic Business Overview
  10. 8.2.3 Medtronic Hemostatis and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Medtronic Hemostatis and Tissue Sealing Agents Product Portfolio
  12. 8.2.5 Medtronic Recent Developments
  13. 8.3 Pfizer Inc.
  14. 8.3.1 Pfizer Inc. Company Information
  15. 8.3.2 Pfizer Inc. Business Overview
  16. 8.3.3 Pfizer Inc. Hemostatis and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Inc. Hemostatis and Tissue Sealing Agents Product Portfolio
  18. 8.3.5 Pfizer Inc. Recent Developments
  19. 8.4 Smith & Nephew
  20. 8.4.1 Smith & Nephew Company Information
  21. 8.4.2 Smith & Nephew Business Overview
  22. 8.4.3 Smith & Nephew Hemostatis and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Smith & Nephew Hemostatis and Tissue Sealing Agents Product Portfolio
  24. 8.4.5 Smith & Nephew Recent Developments
  25. 8.5 Integra Life Sciences Corporation
  26. 8.5.1 Integra Life Sciences Corporation Company Information
  27. 8.5.2 Integra Life Sciences Corporation Business Overview
  28. 8.5.3 Integra Life Sciences Corporation Hemostatis and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Integra Life Sciences Corporation Hemostatis and Tissue Sealing Agents Product Portfolio
  30. 8.5.5 Integra Life Sciences Corporation Recent Developments
  31. 8.6 HyperBranch Medical Technology
  32. 8.6.1 HyperBranch Medical Technology Company Information
  33. 8.6.2 HyperBranch Medical Technology Business Overview
  34. 8.6.3 HyperBranch Medical Technology Hemostatis and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 HyperBranch Medical Technology Hemostatis and Tissue Sealing Agents Product Portfolio
  36. 8.6.5 HyperBranch Medical Technology Recent Developments
  37. 8.7 CryoLife Inc.
  38. 8.7.1 CryoLife Inc. Company Information
  39. 8.7.2 CryoLife Inc. Business Overview
  40. 8.7.3 CryoLife Inc. Hemostatis and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 CryoLife Inc. Hemostatis and Tissue Sealing Agents Product Portfolio
  42. 8.7.5 CryoLife Inc. Recent Developments
  43. 8.8 Cohesion Technologies Inc
  44. 8.8.1 Cohesion Technologies Inc Company Information
  45. 8.8.2 Cohesion Technologies Inc Business Overview
  46. 8.8.3 Cohesion Technologies Inc Hemostatis and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Cohesion Technologies Inc Hemostatis and Tissue Sealing Agents Product Portfolio
  48. 8.8.5 Cohesion Technologies Inc Recent Developments
  49. 8.9 Cohera Medical Inc.
  50. 8.9.1 Cohera Medical Inc. Company Information
  51. 8.9.2 Cohera Medical Inc. Business Overview
  52. 8.9.3 Cohera Medical Inc. Hemostatis and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Cohera Medical Inc. Hemostatis and Tissue Sealing Agents Product Portfolio
  54. 8.9.5 Cohera Medical Inc. Recent Developments
  55. 8.10 C R Bard Inc.
  56. 8.10.1 C R Bard Inc. Company Information
  57. 8.10.2 C R Bard Inc. Business Overview
  58. 8.10.3 C R Bard Inc. Hemostatis and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 C R Bard Inc. Hemostatis and Tissue Sealing Agents Product Portfolio
  60. 8.10.5 C R Bard Inc. Recent Developments
  61. 8.11 Biomet Inc.
  62. 8.11.1 Biomet Inc. Company Information
  63. 8.11.2 Biomet Inc. Business Overview
  64. 8.11.3 Biomet Inc. Hemostatis and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Biomet Inc. Hemostatis and Tissue Sealing Agents Product Portfolio
  66. 8.11.5 Biomet Inc. Recent Developments
  67. 8.12 B Braun Medical Inc.
  68. 8.12.1 B Braun Medical Inc. Company Information
  69. 8.12.2 B Braun Medical Inc. Business Overview
  70. 8.12.3 B Braun Medical Inc. Hemostatis and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 B Braun Medical Inc. Hemostatis and Tissue Sealing Agents Product Portfolio
  72. 8.12.5 B Braun Medical Inc. Recent Developments
  73. 8.13 Advance Medical Solution (AMS) Group Plc.
  74. 8.13.1 Advance Medical Solution (AMS) Group Plc. Company Information
  75. 8.13.2 Advance Medical Solution (AMS) Group Plc. Business Overview
  76. 8.13.3 Advance Medical Solution (AMS) Group Plc. Hemostatis and Tissue Sealing Agents Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Advance Medical Solution (AMS) Group Plc. Hemostatis and Tissue Sealing Agents Product Portfolio
  78. 8.13.5 Advance Medical Solution (AMS) Group Plc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hemostatis and Tissue Sealing Agents Value Chain Analysis
  2. 9.1.1 Hemostatis and Tissue Sealing Agents Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hemostatis and Tissue Sealing Agents Production Mode & Process
  6. 9.2 Hemostatis and Tissue Sealing Agents Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hemostatis and Tissue Sealing Agents Distributors
  9. 9.2.3 Hemostatis and Tissue Sealing Agents Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst